Maybe Linus Pauling was on to something after all. Decades ago the Nobel Prize–winning chemist was relegated to the fringes of medicine after championing the idea that vitamin C could combat a host of illnesses, including cancer. Now, a study published online today in Science reports that vitamin C can kill tumor cells that carry a common cancer-causing mutation and—in mice—can curb the growth of tumors with the mutation. If the findings hold up in people, researchers may have found a way to treat a large swath of tumors that has lacked effective drugs. "This [could] be one answer to the question everybody's striving for," says molecular biologist Channing Der of the University of North Carolina, Chapel Hill, one of many researchers trying to target cancers with the mutation. The study is also gratifying for the handful of researchers pursuing vitamin C, or ascorbic acid, as a cancer drug. Maybe people will finally pay attention," says vitamin C researcher Mark Levine of the National Institute of Diabetes and Digestive and Kidney Diseases.
In 1971, Pauling began collaborating with a Scottish physician who had reported success treating cancer patients with vitamin C. But the failure of two clinical trials of vitamin C pills, conducted in the late 1970s and early 1980s at the Mayo Clinic in Rochester, Minnesota, dampened enthusiasm for Pauling’s idea. Studies by Levine’s group later suggested that the vitamin must be given intravenously to reach doses high enough to kill cancer cells. A few small trials in the past 5 years—for pancreatic and ovarian cancer—hinted that IV vitamin C treatment combined with chemotherapy can extend cancer survival. But doubters were not swayed. "The atmosphere was poisoned" by the earlier failures, Levine says. A few years ago, Jihye Yun, then a graduate student at Johns Hopkins University in Baltimore, Maryland, found that colon cancer cells whose growth is driven by mutations in the gene KRAS or a less commonly mutated gene, BRAF, make unusually large amounts of a protein that transports glucose across the cell membrane.
The transporter, GLUT1, supplies the cells with the high levels of glucose they need to survive. GLUT1 also transports the oxidized form of vitamin C, dehydroascorbic acid (DHA), into the cell, bad news for cancer cells, because Yun found that DHA can deplete a cell’s supply of a chemical that sops up free radicals. Because free radicals can harm a cell in various ways, the finding suggested “a vulnerability” if the cells were flooded with DHA, says Lewis Cantley at Weill Cornell Medicine in New York City, where Yun is now a postdoc. Cantley’s lab and collaborators found that large doses of vitamin C did indeed kill cultured colon cancer cells with BRAF or KRAS mutations by raising free radical levels, which in turn inactivate an enzyme needed to metabolize glucose, depriving the cells of energy. Then they gave daily high dose injections—equivalent to a person eating 300 oranges—to mice engineered to develop KRAS-driven colon tumors. The mice developed fewer and smaller colon tumors compared with control mice.
Cantley hopes to soon start clinical trials that will select cancer patients based on KRAS or BRAF mutations and possibly GLUT1 status. His group’s new study "tells you who should get the drug and who shouldn't," he says. Cancer geneticist Bert Vogelstein of Johns Hopkins University, in whose lab Yun noticed the GLUT1 connection, is excited about vitamin C therapy, not only as a possible treatment for KRAS-mutated colon tumors, which make up about 40% of all colon cancers, but also for pancreatic cancer, a typically lethal cancer driven by KRAS. “No KRAS-targeted therapeutics have emerged despite decades of effort and hundreds of millions of dollars [spent] by both industry and academia,” Vogelstein says. Others caution that the effects seen in mice may not hold up in humans. But because high dose vitamin C is already known to be safe, says cancer researcher Vuk Stambolic of the University of Toronto in Canada, oncologists “can quickly move forward in the clinic." One drawback is that patients will have to come into a clinic for vitamin C infusions, ideally every few days for months, because vitamin C seems to take that long to kill cancer cells, Levine notes.
But Cantley says it may be possible to make an oral formulation that reaches high doses in the blood—which may be one way to get companies interested in sponsoring trials.Having a healthy immune system is vital in fighting off illnesses, recovering quickly from injuries, and making surgeries as successful as possible. However, many people do not have strong immune systems or are seriously lacking in various areas of health. Whether you are looking to improve your immune system for a healthier everyday life or are preparing for an upcoming medical procedure, boosting your immune system can get great results fast.However, healthy dieting and oral vitamins are not as effective as many people believe, especially when time is of the essence. Intravenous (IV) therapy can provide vitamins, minerals, and other nutrient faster and more effectively than oral supplements, helping you to improve your immune system in as little time as possible. Understanding how these procedures work and what they can do for you will help you get on the road to recovery in as little time as possible.
At the IV Therapy Center of Beverly Hills, our medical team has helped countless patients receive the vitamin therapies they need in order to return to an optimal state of health. To learn more about how we can create a unique plan for your needs, contact us online or call us today at (310) 550-8000.Interested in IV Therapy?(310) 550-8000The complex systems of the body run on a consistent supply of nutrients. While a person’s daily diet may supply a large amount of this nutrition, they may be lacking in many areas that even the most well balanced food cannot cover. Many individuals believe that taking oral vitamins and supplements will fill this gap, but the truth is that a large portion of every vitamin taken will never be processed by the body. This means that only a fraction of the supplements you are taking will actually support your body’s systems. Taking larger doses will not help either, as it is simply too much for your body to process and may only end in digestive system complications.
The reason that IV vitamin therapy has become so popular is because it allows for a way around these shortcomings. By delivering needed vitamins and minerals directly into the blood stream, your body is able to not only process these nutrients more directly, but can absorb a far higher dose at one time. An evaluation by a medical professional will determine the current state of your body, what your goals for recovery should be, and the exact amounts of nutrients that are needed in order to get you there.Since all IV therapy is done under the supervision of an experienced medical team, you can leave the details up to them while you relax and recuperate.Each person’s complex immune system works hard every day in order to fight off infections and diseases encountered in normal life. However, poor health, age, and other factors can weaken the system, allowing for more severe or more frequent illnesses. Research has shown that good nutrition can help immune systems return to their former strength quickly, which is especially important for people who have undergone surgery, are more advanced in age, or who have been consistently dealing with a compromised immune system.